Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Extracellular Vesicles as an Advanced Delivery Biomaterial for Precision Cancer Immunotherapy
Shaobo Ruan, Zachary Greenberg, Xiaoshu Pan, et al.
Advanced Healthcare Materials (2021) Vol. 11, Iss. 5
Open Access | Times Cited: 41

Showing 1-25 of 41 citing articles:

Towards artificial intelligence-enabled extracellular vesicle precision drug delivery
Zachary Greenberg, Kiley Graim, Mei He
Advanced Drug Delivery Reviews (2023) Vol. 199, pp. 114974-114974
Closed Access | Times Cited: 39
Exosome membrane-coated nanosystems: Exploring biomedical applications in cancer diagnosis and therapy
Minmin Shao, Daniela Lopes, Joana Lopes, et al.
Matter (2023) Vol. 6, Iss. 3, pp. 761-799
Open Access | Times Cited: 29
Glioblastoma cell-derived exosomes functionalized with peptides as efficient nanocarriers for synergistic chemotherapy of glioblastoma with improved biosafety
Ying Zhou, Long Wang, Lufei Chen, et al.
Nano Research (2023) Vol. 16, Iss. 12, pp. 13283-13293
Closed Access | Times Cited: 25
Biomarkers for prediction of CAR T therapy outcomes: current and future perspectives
Lucija Levstek, Larisa Janžič, Alojz Ihan, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 11
Circular RNAs in tumor immunity and immunotherapy
Wenjie Zhang, Xu Chen, Zhipeng Yang, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 9
Lipid-Based Nanovesicular Drug Delivery Systems
Tania Limongi, Francesca Susa, Monica Marini, et al.
Nanomaterials (2021) Vol. 11, Iss. 12, pp. 3391-3391
Open Access | Times Cited: 45
Extracellular vesicles in pancreatic cancer immune escape: Emerging roles and mechanisms
Chunping Liu, Dongyue He, Longmei Li, et al.
Pharmacological Research (2022) Vol. 183, pp. 106364-106364
Closed Access | Times Cited: 33
Engineered Extracellular Vesicles as a Targeted Delivery Platform for Precision Therapy
Yuntong Sun, Fengtian Sun, Wenrong Xu, et al.
Tissue Engineering and Regenerative Medicine (2023) Vol. 20, Iss. 2, pp. 157-175
Open Access | Times Cited: 21
Exosomes as drug delivery systems in glioma immunotherapy
Xinqing Hao, Shiming Wang, Liang Wang, et al.
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 6
Targeting Capabilities of Native and Bioengineered Extracellular Vesicles for Drug Delivery
Liubov Frolova, Isaac T. S. Li
Bioengineering (2022) Vol. 9, Iss. 10, pp. 496-496
Open Access | Times Cited: 25
Functions and therapeutic potentials of exosomes in osteosarcoma
Jiaji Yue, Zhe‐Sheng Chen, Xiang‐Xi Xu, et al.
Acta Materia Medica (2022) Vol. 1, Iss. 4
Open Access | Times Cited: 24
Extracellular vesicles: A new diagnostic biomarker and targeted drug in osteosarcoma
Xiaozhuo Gao, Bo Gao, Shenglong Li
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 23
Recent progresses of exosome–liposome fusions in drug delivery
Lulu Zheng, Bo Hu, Deyao Zhao, et al.
Chinese Chemical Letters (2023) Vol. 35, Iss. 2, pp. 108647-108647
Closed Access | Times Cited: 16
Engineered dendritic cells-derived exosomes harboring HIV-1 Nefmut-Tat fusion protein and heat shock protein 70: A promising HIV-1 safe vaccine candidate
Parisa Moradi Pordanjani, Azam Bolhassani, Mohammad Hassan Pouriayevali, et al.
International Journal of Biological Macromolecules (2024) Vol. 270, pp. 132236-132236
Closed Access | Times Cited: 5
Tumor Microenvironment-Derived Exosomes: A Double-Edged Sword for Advanced T Cell-Based Immunotherapy
Ye Lu, Jiarong Zheng, Pei Lin, et al.
ACS Nano (2024)
Closed Access | Times Cited: 5
Cellular nanovesicles for therapeutic immunomodulation: A perspective on engineering strategies and new advances
Endong Zhang, Philana Phan, Zongmin Zhao
Acta Pharmaceutica Sinica B (2022) Vol. 13, Iss. 5, pp. 1789-1827
Open Access | Times Cited: 21
Biomimetic Cell-Derived Nanoparticles: Emerging Platforms for Cancer Immunotherapy
Tingting Hu, Yuezhou Huang, Jing Liu, et al.
Pharmaceutics (2023) Vol. 15, Iss. 7, pp. 1821-1821
Open Access | Times Cited: 11
Biodelivery of therapeutic extracellular vesicles: should mononuclear phagocytes always be feared?
Martyna Cieślik, Krzysztof Bryniarski, Katarzyna Nazimek
Frontiers in Cell and Developmental Biology (2023) Vol. 11
Open Access | Times Cited: 11
Engineering Cell-Derived Nanovesicles for Targeted Immunomodulation
Adil Ali Sayyed, Piyush Gondaliya, Irene K. Yan, et al.
Nanomaterials (2023) Vol. 13, Iss. 20, pp. 2751-2751
Open Access | Times Cited: 11
Extracellular Vesicle‐Based Antitumor Nanomedicines
Mingfeng Li, Yanfei Liu, Fei Liu, et al.
Advanced Healthcare Materials (2025)
Closed Access
Engineered dendritic cells-derived extracellular vesicles for cancer immunotherapy
Miguel Coelho, Sofia Torres Quintas, Bruno Sarmento, et al.
Journal of Controlled Release (2025), pp. 113620-113620
Closed Access
Neoantigen-based immunotherapy: advancing precision medicine in cancer and glioblastoma treatment through discovery and innovation
Moawiah M. Naffaa, Ola A Al-Ewaidat, Sopiko Gogia, et al.
Exploration of Targeted Anti-tumor Therapy (2025) Vol. 6
Open Access
Fibroblast Growth Factor Receptor 1-Bound Extracellular Vesicle as Novel Therapy for Osteoarthritis
Bryan Gervais de Liyis, John P. Nolan, Made Agus Maharjana
Biomedicine (2022) Vol. 12, Iss. 2, pp. 1-9
Open Access | Times Cited: 16
Extracellular vesicles for developing targeted hearing loss therapy
Xiaoshu Pan, Yanjun Li, Peixin Huang, et al.
Journal of Controlled Release (2024) Vol. 366, pp. 460-478
Closed Access | Times Cited: 3
Strategies for small extracellular vesicle-based cancer immunotherapy
Yundi Chen, Shasha Tang, Fengfeng Cai, et al.
Research (2024) Vol. 7
Open Access | Times Cited: 3
Page 1 - Next Page

Scroll to top